Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Research And Development Expense of $8.26 million for the year ending 2025.
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -3.7% in Research And Development Expense from 2024 to 2025.
- This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $2.34 million | Q1 2012: $2.47 million | Q3 2012: $2.20 million | Q4 2012: $2.11 million | Q1 2013: $2.33 million | Q3 2013: $1.93 million | Q4 2013: $1.92 million | Q1 2014: $1.72 million | Q3 2014: $1.80 million | Q4 2014: $1.83 million | Q1 2015: $1.76 million | Q3 2015: $1.88 million | Q4 2015: $1.64 million | Q1 2016: $1.90 million | Q3 2016: $1.94 million | Q4 2016: $1.97 million | Q1 2017: $2.01 million | Q3 2017: $2.72 million | Q4 2017: $3.37 million | Q1 2018: $3.11 million | Q3 2018: $2.79 million | Q4 2018: $2.48 million | Q1 2019: $2.74 million | Q3 2019: $2.82 million | Q4 2019: $2.82 million | Q1 2020: $2.75 million | Q3 2020: $1.74 million | Q4 2020: $1.59 million | Q1 2021: $1.64 million | Q3 2021: $1.69 million | Q4 2021: $1.68 million | Q1 2022: $2.25 million | Q3 2022: $2.21 million | Q4 2022: $2.18 million | Q1 2023: $2.23 million | Q3 2023: $2.15 million | Q4 2023: $2.10 million | Q1 2024: $2.17 million | Q3 2024: $2.19 million | Q4 2024: $1.92 million | Q1 2025: $2.05 million | Q3 2025: $1.96 million.
- Over the full 16 years of available data (2010 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Research And Development Expense has grown by 89.4%.
- Historical annual values: Fiscal year 2025: $8.26 million | Fiscal year 2024: $8.58 million | Fiscal year 2023: $8.74 million | Fiscal year 2022: $7.84 million | Fiscal year 2021: $6.68 million | Fiscal year 2020: $7.58 million | Fiscal year 2019: $11.47 million | Fiscal year 2018: $12.80 million | Fiscal year 2017: $9.47 million | Fiscal year 2016: $7.23 million | Fiscal year 2015: $6.99 million | Fiscal year 2014: $7.20 million | Fiscal year 2013: $9.29 million | Fiscal year 2012: $9.63 million | Fiscal year 2011: $9.28 million | Fiscal year 2010: $4.36 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: